Progress in moyamoya disease

S Shang, D Zhou, J Ya, S Li, Q Yang, Y Ding, X Ji… - Neurosurgical …, 2020 - Springer
Moyamoya disease is characterized by progressive stenosis or occlusion of the intracranial
portion of the internal carotid artery and their proximal branches, resulting in ischemic or …

European stroke organisation (ESO) guidelines on moyamoya angiopathy endorsed by vascular european reference network (VASCERN)

A Bersano, N Khan, B Fuentes, F Acerbi… - European Stroke …, 2023 - journals.sagepub.com
The European Stroke Organisation (ESO) guidelines on Moyamoya Angiopathy (MMA),
developed according to ESO standard operating procedure and Grading of …

Imaging of moyamoya disease and moyamoya syndrome: current status

J Li, M Jin, X Sun, J Li, Y Liu, Y Xi, Q Wang… - Journal of Computer …, 2019 - journals.lww.com
Moyamoya disease (MMD) and Moyamoya syndrome (MMS) are referring to a progressive
steno-occlusive vasculopathy at terminal portions of the bilateral internal carotid arteries and …

Modifiable risk factors associated with moyamoya disease: a case-control study

P Ge, Q Zhang, X Ye, X Liu, X Deng, J Wang, R Wang… - Stroke, 2020 - Am Heart Assoc
Background and Purpose: The cause of moyamoya disease (MMD) remains unknown. We
aimed to investigate the association between modifiable risk factors and MMD in a …

Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study

Y Sun, G Zhou, J Feng, L Chen, G Liu… - Stroke and vascular …, 2021 - svn.bmj.com
Background and objective Moyamoya disease (MMD) is an increasingly recognised cause
of stroke, mainly described in East Asia. China is the largest nation in Asia, but few studies …

Clinical management of moyamoya patients

I Canavero, IG Vetrano, M Zedde, R Pascarella… - Journal of Clinical …, 2021 - mdpi.com
Moyamoya angiopathy (MMA) is a peculiar cerebrovascular condition characterized by
progressive steno-occlusion of the terminal part of the internal carotid arteries (ICAs) and …

Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study

X Deng, F Gao, D Zhang, Y Zhang, R Wang… - Journal of …, 2017 - thejns.org
OBJECTIVE Bypass surgery is the most common treatment for moyamoya disease (MMD),
but there is controversy over which surgical modality is best. The objective of this study was …

Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults

DK Jang, KS Lee, HK Rha, PW Huh, JH Yang… - Journal of …, 2016 - thejns.org
OBJECTIVE In this study the authors evaluated whether extracranial-intracranial bypass
surgery can prevent stroke occurrence and decrease mortality in adult patients with …

RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance

Q Zhang, Y Liu, D Zhang, R Wang, Y Zhang… - Journal of …, 2017 - thejns.org
OBJECTIVE Moyamoya disease (MMD) is a rare, genetically heterogeneous
cerebrovascular disease. The authors conducted a genetic study of really interesting new …

Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis

Y Araki, K Yokoyama, K Uda, F Kanamori… - Neurosurgical …, 2021 - Springer
Stroke and neurological outcomes in the early phase following revascularization for
moyamoya disease (MMD) may depend on the patient's age. In this study, an age-stratified …